BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27639686)

  • 1. A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac Support.
    Thomas GR; McDonald MA; Day J; Ross HJ; Delgado DH; Billia F; Butany JW; Rao V; Amir E; Bedard PL; Thavendiranathan P
    Am J Cardiol; 2016 Nov; 118(10):1539-1544. PubMed ID: 27639686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.
    Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
    Tex Heart Inst J; 2015 Apr; 42(2):124-30. PubMed ID: 25873821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Oliveira GH; Dupont M; Naftel D; Myers SL; Yuan Y; Tang WH; Gonzalez-Stawinski G; Young JB; Taylor DO; Starling RC
    J Am Coll Cardiol; 2014 Jan; 63(3):240-8. PubMed ID: 24161324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.
    Mukku RB; Fonarow GC; Watson KE; Ajijola OA; Depasquale EC; Nsair A; Baas AS; Deng MC; Yang EH
    J Card Fail; 2016 Jun; 22(6):439-48. PubMed ID: 27109619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation.
    Oliveira GH; Hardaway BW; Kucheryavaya AY; Stehlik J; Edwards LB; Taylor DO
    J Heart Lung Transplant; 2012 Aug; 31(8):805-10. PubMed ID: 22551930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ventricular assist device implantation as a bridge to cardiac transplantation in two adolescents with end-stage cardiomyopathy and heart failure as a result of anthracycline use].
    Berends M; van Bokhoven MM; van de Luijtgaarden A; Bellersen LB; van Hoesel QC; van Herpen CM
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2088-92. PubMed ID: 18837186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support.
    Loyaga-Rendon RY; Pamboukian SV; Tallaj JA; Acharya D; Cantor R; Starling RC; Naftel D; Kirklin J
    Circ Heart Fail; 2014 Mar; 7(2):300-9. PubMed ID: 24443515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy.
    Rickard J; Kumbhani DJ; Baranowski B; Martin DO; Tang WH; Wilkoff BL
    Am J Cardiol; 2010 Feb; 105(4):522-6. PubMed ID: 20152248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction.
    Krasnopero D; Asante-Korang A; Jacobs JP; Stapleton S; Carapellucci J; Dotson M; Stapleton G
    Cardiol Young; 2018 Mar; 28(3):471-475. PubMed ID: 29198224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological assessment of end-stage heart failure in explanted hearts in correlation with hemodynamics in patients undergoing orthotopic heart transplantation.
    Ottaviani G; Radovancevic R; Kar B; Gregoric I; Buja LM
    Cardiovasc Pathol; 2015; 24(5):283-9. PubMed ID: 26129629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Heart Failure Therapies for Cancer Therapeutics-Related Cardiac Dysfunction.
    Bianco CM; Al-Kindi SG; Oliveira GH
    Heart Fail Clin; 2017 Apr; 13(2):327-336. PubMed ID: 28279418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy.
    Oliveira GH; Qattan MY; Al-Kindi S; Park SJ
    Circ Heart Fail; 2014 Nov; 7(6):1050-8. PubMed ID: 25415958
    [No Abstract]   [Full Text] [Related]  

  • 14. Perioperative mortality is the Achilles heel for cardiac transplantation in adults with congenital heart disease: Evidence from analysis of the UNOS registry.
    Shah DK; Deo SV; Althouse AD; Teuteberg JJ; Park SJ; Kormos RL; Burkhart HM; Morell VO
    J Card Surg; 2016 Dec; 31(12):755-764. PubMed ID: 27709686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation.
    Guha A; Caraballo C; Jain P; Miller PE; Owusu-Guha J; Clark KAA; Velazquez EJ; Ahmad T; Baldassarre LA; Addison D; Weintraub NL; Desai NR
    ESC Heart Fail; 2021 Aug; 8(4):2866-2875. PubMed ID: 33982867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure.
    Araujo-Gutierrez R; Ibarra-Cortez SH; Estep JD; Bhimaraj A; Guha A; Hussain I; Park MH; Torre-Amione G; Trachtenberg BH
    Cardiooncology; 2018; 4():3. PubMed ID: 32154004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias in children with ventricular assist devices.
    Kyle WB; Decker J; Macicek SL; Valdes SO; Morales D; Hong B; Price JF; Dreyer WJ; Denfield SW; Kim JJ
    Cardiol Young; 2015 Feb; 25(2):255-60. PubMed ID: 25647466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation.
    Rosenthal DG; Anderson ME; Petek BJ; Arnett DM; Bravo PE; Raghu G; Goldberger ZD; Patton KK; Cheng RK
    Can J Cardiol; 2018 Aug; 34(8):978-982. PubMed ID: 30049365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.